Research and development (including 1,375,000, 4,625,000, 2,750,000 and 6,000,000 from a related party for the three months ended june 30, 2026 and 2025 and the six months ended june 30, 2026 and 2025, respectively)
1,400,232
1,400,275
-2,969,594.5*
4,152,642
General and administrative (including 63,231, 65,151, 133,177 and 129,586 from related parties for the three months ended june 30, 2026 and 2025 and the six months ended june 30, 2026 and 2025, respectively)
684,015
891,789
515,778*
648,507
Total operating expenses
2,084,247
2,292,064
-2,453,816.5
4,801,149
Gain from operations
-2,084,247
-2,292,064
2,453,816.5
-4,801,149
Change in fair value of derivative liabilities
222,092
-
-
-
Total other expenses
-222,092
-
-
-
Gain before income tax
-2,306,339
-2,292,064
2,453,816.5*
-4,801,149
Income tax provision
-
-
-1,712*
-
Net gain
-2,306,339
-2,292,064
2,455,528.5
-4,801,149
Basic EPS
-0.05
-0.05
0.066
-0.13
Diluted EPS
-0.05
-0.05
0.066
-0.13
Basic Average Shares
42,997,733
42,121,075
37,200,817
37,096,024
Diluted Average Shares
42,997,733
42,121,075
37,200,817
37,096,024
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.